Annual Revenue
$58.44 M
+$6.95 M+13.49%
December 31, 2023
Summary
- As of February 7, 2025, OCUL annual revenue is $58.44 million, with the most recent change of +$6.95 million (+13.49%) on December 31, 2023.
- During the last 3 years, OCUL annual revenue has risen by +$41.04 million (+235.82%).
- OCUL annual revenue is now at all-time high.
Performance
OCUL Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$15.43 M
-$1.02 M-6.18%
September 30, 2024
Summary
- As of February 7, 2025, OCUL quarterly revenue is $15.43 million, with the most recent change of -$1.02 million (-6.18%) on September 30, 2024.
- Over the past year, OCUL quarterly revenue has increased by +$344.00 thousand (+2.28%).
- OCUL quarterly revenue is now -6.18% below its all-time high of $16.44 million, reached on June 30, 2024.
Performance
OCUL Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$61.44 M
+$344.00 K+0.56%
September 30, 2024
Summary
- As of February 7, 2025, OCUL TTM revenue is $61.44 million, with the most recent change of +$344.00 thousand (+0.56%) on September 30, 2024.
- Over the past year, OCUL TTM revenue has increased by +$3.73 million (+6.45%).
- OCUL TTM revenue is now at all-time high.
Performance
OCUL TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
OCUL Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +13.5% | +2.3% | +6.5% |
| 3 y3 years | +235.8% | +26.9% | +59.3% |
| 5 y5 years | +2836.8% | +1760.7% | +1353.5% |
OCUL Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +34.3% | -6.2% | +28.9% | at high | +41.2% |
| 5 y | 5-year | at high | +1282.6% | -6.2% | +883.1% | at high | +1353.5% |
| alltime | all time | at high | >+9999.0% | -6.2% | >+9999.0% | at high | >+9999.0% |
Ocular Therapeutix Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $15.43 M(-6.2%) | $61.44 M(+0.6%) |
| Jun 2024 | - | $16.44 M(+11.3%) | $61.10 M(+2.1%) |
| Mar 2024 | - | $14.77 M(-0.2%) | $59.84 M(+2.4%) |
| Dec 2023 | $58.44 M(+13.5%) | $14.80 M(-1.9%) | $58.44 M(+1.3%) |
| Sep 2023 | - | $15.08 M(-0.7%) | $57.72 M(+5.7%) |
| Jun 2023 | - | $15.19 M(+13.5%) | $54.60 M(+5.7%) |
| Mar 2023 | - | $13.37 M(-5.0%) | $51.68 M(+0.4%) |
| Dec 2022 | $51.49 M(+18.3%) | $14.07 M(+17.6%) | $51.49 M(+3.6%) |
| Sep 2022 | - | $11.96 M(-2.5%) | $49.73 M(-0.4%) |
| Jun 2022 | - | $12.27 M(-7.0%) | $49.91 M(+1.1%) |
| Mar 2022 | - | $13.19 M(+7.1%) | $49.37 M(+13.4%) |
| Dec 2021 | $43.52 M(+150.1%) | $12.31 M(+1.3%) | $43.52 M(+12.9%) |
| Sep 2021 | - | $12.15 M(+3.7%) | $38.56 M(+19.4%) |
| Jun 2021 | - | $11.72 M(+59.6%) | $32.28 M(+45.8%) |
| Mar 2021 | - | $7.34 M(-0.1%) | $22.14 M(+27.2%) |
| Dec 2020 | $17.40 M(+311.7%) | $7.35 M(+25.1%) | $17.40 M(+41.4%) |
| Sep 2020 | - | $5.88 M(+274.5%) | $12.31 M(+69.5%) |
| Jun 2020 | - | $1.57 M(-39.9%) | $7.26 M(+14.5%) |
| Mar 2020 | - | $2.61 M(+15.6%) | $6.34 M(+50.1%) |
| Dec 2019 | $4.23 M | $2.26 M(+172.1%) | $4.23 M(+70.8%) |
| Sep 2019 | - | $829.00 K(+27.5%) | $2.48 M(+15.4%) |
| Jun 2019 | - | $650.00 K(+32.1%) | $2.14 M(+0.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | $492.00 K(-2.4%) | $2.14 M(+7.6%) |
| Dec 2018 | $1.99 M(+3.5%) | $504.00 K(+1.2%) | $1.99 M(+0.9%) |
| Sep 2018 | - | $498.00 K(-23.1%) | $1.97 M(-1.3%) |
| Jun 2018 | - | $648.00 K(+90.6%) | $2.00 M(+11.7%) |
| Mar 2018 | - | $340.00 K(-30.2%) | $1.79 M(-7.0%) |
| Dec 2017 | $1.92 M(+1.9%) | $487.00 K(-6.9%) | $1.92 M(-1.2%) |
| Sep 2017 | - | $523.00 K(+19.4%) | $1.95 M(+2.4%) |
| Jun 2017 | - | $438.00 K(-7.8%) | $1.90 M(-0.2%) |
| Mar 2017 | - | $475.00 K(-7.0%) | $1.90 M(+0.9%) |
| Dec 2016 | $1.89 M(+7.8%) | $511.00 K(+7.1%) | $1.89 M(+4.1%) |
| Sep 2016 | - | $477.00 K(+8.2%) | $1.81 M(+2.7%) |
| Jun 2016 | - | $441.00 K(-3.7%) | $1.76 M(-1.0%) |
| Mar 2016 | - | $458.00 K(+5.0%) | $1.78 M(+1.8%) |
| Dec 2015 | $1.75 M(+126.7%) | $436.00 K(+1.6%) | $1.75 M(-3.8%) |
| Sep 2015 | - | $429.00 K(-6.5%) | $1.82 M(+18.7%) |
| Jun 2015 | - | $459.00 K(+7.7%) | $1.53 M(+30.9%) |
| Mar 2015 | - | $426.00 K(-15.6%) | $1.17 M(+51.7%) |
| Dec 2014 | $772.00 K(+7620.0%) | $505.00 K(+253.1%) | $772.00 K(+189.1%) |
| Sep 2014 | - | $143.00 K(+47.4%) | $267.00 K(+115.3%) |
| Jun 2014 | - | $97.00 K(+259.3%) | $124.00 K(+359.3%) |
| Mar 2014 | - | $27.00 K | $27.00 K |
| Dec 2012 | $10.00 K | - | - |
FAQ
- What is Ocular Therapeutix annual revenue?
- What is the all time high annual revenue for Ocular Therapeutix?
- What is Ocular Therapeutix annual revenue year-on-year change?
- What is Ocular Therapeutix quarterly revenue?
- What is the all time high quarterly revenue for Ocular Therapeutix?
- What is Ocular Therapeutix quarterly revenue year-on-year change?
- What is Ocular Therapeutix TTM revenue?
- What is the all time high TTM revenue for Ocular Therapeutix?
- What is Ocular Therapeutix TTM revenue year-on-year change?
What is Ocular Therapeutix annual revenue?
The current annual revenue of OCUL is $58.44 M
What is the all time high annual revenue for Ocular Therapeutix?
Ocular Therapeutix all-time high annual revenue is $58.44 M
What is Ocular Therapeutix annual revenue year-on-year change?
Over the past year, OCUL annual revenue has changed by +$6.95 M (+13.49%)
What is Ocular Therapeutix quarterly revenue?
The current quarterly revenue of OCUL is $15.43 M
What is the all time high quarterly revenue for Ocular Therapeutix?
Ocular Therapeutix all-time high quarterly revenue is $16.44 M
What is Ocular Therapeutix quarterly revenue year-on-year change?
Over the past year, OCUL quarterly revenue has changed by +$344.00 K (+2.28%)
What is Ocular Therapeutix TTM revenue?
The current TTM revenue of OCUL is $61.44 M
What is the all time high TTM revenue for Ocular Therapeutix?
Ocular Therapeutix all-time high TTM revenue is $61.44 M
What is Ocular Therapeutix TTM revenue year-on-year change?
Over the past year, OCUL TTM revenue has changed by +$3.73 M (+6.45%)